SCHEMBL29295506

SCHEMBL29295506

COC(=O)c1ccc(Br)cc1SCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.52
▸ PKM P14618 1/20 0.52
▸ PTPRC P08575 1/20 0.51
▸ PTPRG P23470 1/20 0.51
▸ ALDH1A1 P00352 4/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ GAA P10253 1/20 0.46
▸ KMT2A Q03164 4/20 0.46
▸ POLB P06746 2/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ HPGD P15428 3/20 0.45
▸ CYP1A2 P05177 2/20 0.45
▸ CYP3A4 P08684 2/20 0.45
▸ CYP2C9 P11712 2/20 0.45
▸ CYP2C19 P33261 2/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ MEN1 O00255 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ CA12 O43570 2/20 0.43
▸ CA1 P00915 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11715445 0.85 L3MBTL1 (0.53) L3MBTL1PKMALDH1A1TDP1GAA
SCHEMBL30016479 0.85 PTPRC (0.54) L3MBTL1PTPRCPTPRGALDH1A1KMT2A
SCHEMBL18769941 0.85 PTPRC (0.54) L3MBTL1PTPRCPTPRGALDH1A1KMT2A
SCHEMBL30016005 0.84 PTPRC (0.68) L3MBTL1PTPRCPTPRGALDH1A1GAA
SCHEMBL11719632 0.84 L3MBTL1 (0.52) L3MBTL1PKMPTPRCALDH1A1TDP1
SCHEMBL11712860 0.84 L3MBTL1 (0.52) L3MBTL1PKMALDH1A1TDP1GAA
SCHEMBL8628655 0.83 POLB (0.65) L3MBTL1PKMPTPRGALDH1A1TDP1
SCHEMBL28298585 0.83 L3MBTL1 (0.51) L3MBTL1PKMALDH1A1TDP1GAA
SCHEMBL28109773 0.82 KMT2A (0.64) L3MBTL1PTPRCPTPRGALDH1A1KMT2A
SCHEMBL11714137 0.82 L3MBTL1 (0.50) L3MBTL1PKMALDH1A1TDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240226115-A1 AXL INHIBITOR COMPOUNDS ARCUS BIOSCIENCES, INC. 2024-07-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240226115-A1 AXL INHIBITOR COMPOUNDS AXL, BTK, MERTK L3MBTL1 1171/4885PKM 1412/4885PTPRC 416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback